LSE:AMS

Advanced Medical Solutions Group plc · LSE · Healthcare · GBP · FY for 2025

Figures on this page computed 2026-11-08 12:46 UTC

Last close

n/aGBp

Market data

61.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed
- Computed from the filing for 2025
3.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
4.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
9.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
0.32Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
0.9%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed

What it pays out is the furthest below its sector's middle: 0.36 against 0.44 on the market's range.

All from 100

lens 2 of 9

Sales

275

2016-12-31 to 2025-12-31100 at the start275

Sales: 100.00 on 2016-12-31 to 275.02 on 2025-12-31, up 175%.

Profit

63.4

2016-12-31 to 2025-12-31100 at the start63.4

Profit: 100.00 on 2016-12-31 to 63.43 on 2025-12-31, down 37%.

Shares in issue

103

2016-12-31 to 2025-12-31100 at the start103

Shares in issue: 100.00 on 2016-12-31 to 103.49 on 2025-12-31, up 3%.

Sales is at 275, Profit is at 63, Shares in issue is at 104, against 100 in 2016.

Sales is at 275, Profit is at 63, Shares in issue is at 104, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100275
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Profit, where the first year is 10063
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Shares in issue, where the first year is 100104
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP